Science

Apr 29, 2025, 16:14

Myeloma Paper of the Day, April 29th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Immune profiling of smoldering myeloma patients treated with vaccine targeting XBP1/CD138/CS1 + HDACi citarinostat +/- len finds more B intermediate, CD8 effector memory and B memory cells, fewer plasmablasts and CD4 prolif. cells.”

“Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide”

Authors: Diana Cirstea, Rajib Shome, Mehmet Samur, Srikanth Talluri, Joseph Connolly, Cristiana Costa Chase, Ehsan Malek, Ruben Niesvizky, Paul Richardson, Noopur Raje et al.

More posts featuring Robert Orlowski.

cancer Cristiana Costa Chase Diana Cirstea Ehsan Malek Joseph Connolly Mehmet Samur Myeloma Paper of the Day Noopur Raje OncoDaily Oncology Paul Richardson Rajib Shome Robert Orlowski Ruben Niesvizky Smoldering multiple myeloma Srikanth Talluri

ASCO 2025 for Trainees and Residents: Your Ultimate Guide to Success

ctDNA after surgery for MMRd tumors can prevent cancer recurrence - Yelena Janjigian at AACR25

Top Growing Medical Universities in the Post-Soviet Region – BIGR 2025 Edition

Organ Preservation in dMMR Tumors: Results from Neoadjuvant Phase II Study with Dostarlimab

POEM 2025 Scientific Meeting: Key Sessions, Workshops, and Why You Should Attend